Becton, Dickinson and Co. | BDX - Operating Profit

Stock Price
201.91
Daily Change
-1.57 -0.77%
Monthly
1.48%
Yearly
-18.46%
Q1 Forecast
197.21

Becton, Dickinson and Co. reported $826M in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
Abbott USD 2.25B 73M Dec/2025
Agilent USD 443M 66M Sep/2025
Align Technology USD 184.65M 21.61M Sep/2025
Avanos Medical USD 18.97M 72.63M Sep/2025
Baxter International USD 201.2M 70.8M Sep/2025
Becton, Dickinson and Co. USD 826M 153M Sep/2025
Bio-Rad Laboratories USD 77.1M 53.4M Jun/2025
Boston Scientific USD 1.04B 98M Sep/2025
Cooper Companies USD 140.4M 35.3M Sep/2025
Danaher USD 1.5B 348M Dec/2025
Dentsply International USD 512M 401M Sep/2025
Dexcom USD 242.5M 29.9M Sep/2025
Edwards Lifesciences USD 425.1M 5.8M Sep/2025
Exact Sciences USD -25M 22.85M Sep/2025
Globus Medical USD -117.52M 8.43M Sep/2025
Hologic USD 237M 16M Dec/2025
Insulet USD 117.7M 3.4M Sep/2025
Integra LifeSciences USD 11.76M 13.07M Sep/2025
Intuitive Surgical USD 865.3M 97.5M Dec/2025
J&J USD 5.59B 1.81B Dec/2025
Masimo USD 83.6M 19.1M Sep/2025
Medtronic USD 1.7B 100M Sep/2025
Solventum Corp USD 1.69B 1.47B Sep/2025
Stryker USD 1.97B 609M Dec/2025
Tandem Diabetes Care USD -22.86M 9M Sep/2025
Teleflex USD -408.9M 586.38M Sep/2025
Terumo JPY 45.1B 10.79B Sep/2025
Thermo Fisher Scientific USD 2.3B 226M Dec/2025
Zimmer Biomet Holdings USD 338.3M 58.1M Sep/2025